Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Leukemia, Myeloid, Acute 78Myelodysplastic Syndromes 75Precursor Cell Lymphoblastic Leukemia-Lymphoma 70Leukemia, Lymphocytic, Chronic, B-Cell 58Leukemia 55Hodgkin Disease 55Lymphoma, Non-Hodgkin 54Lymphoma 48Multiple Myeloma 45Myeloproliferative Disorders 41Lymphoma, Follicular 40Graft vs Host Disease 38Lymphoma, Mantle-Cell 36Lymphoma, Large B-Cell, Diffuse 36Leukemia, Myelomonocytic, Chronic 36Lymphoma, B-Cell, Marginal Zone 35Leukemia, Myeloid, Accelerated Phase 34Leukemia, Myelogenous, Chronic, BCR-ABL Positive 33Congenital Abnormalities 33Burkitt Lymphoma 33Leukemia, Myeloid, Chronic-Phase 29Primary Myelofibrosis 28Hematologic Neoplasms 28Neoplasms, Plasma Cell 24Lymphoma, Large-Cell, Immunoblastic 24Blast Crisis 24Waldenstrom Macroglobulinemia 20Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 19Myelodysplastic-Myeloproliferative Diseases 18Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17

Interventions

Doxorubicin 62Ifosfamide 39Gemcitabine 29Radiotherapy 27Filgrastim 27Cyclophosphamide 26Docetaxel 19Vincristine 18pembrolizumab 17Etoposide 17pazopanib 16Cisplatin 16Nivolumab 15Trabectedin 14apatinib 13Magnetic Resonance Spectroscopy 13Carboplatin 12Irinotecan 11Bevacizumab 11anlotinib 10Temozolomide 10Surgical Procedures, Operative 10Sirolimus 10camrelizumab 9Sorafenib 9Paclitaxel 9Ipilimumab 9Injections 9Dactinomycin 9Topotecan 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Sarcoma × Tacrolimus × Clear all
NCT00043979 2017-05-31

Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
60 enrolled 31 charts
Sarcoma

Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡